NO996580L - 5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate - Google Patents
5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleateInfo
- Publication number
- NO996580L NO996580L NO996580A NO996580A NO996580L NO 996580 L NO996580 L NO 996580L NO 996580 A NO996580 A NO 996580A NO 996580 A NO996580 A NO 996580A NO 996580 L NO996580 L NO 996580L
- Authority
- NO
- Norway
- Prior art keywords
- tetrazol
- ethyl
- methyl
- tetrahydropyridine
- maleate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Den foreliggende oppfinnelse vedrører et maleatsyre- addisjonssalt av 5-(2-etyl-2tf-tetrazol-5-yl)-1-metyl- 1,2,3,6-tetrahydropyridin, farmasøytiske sammensetninger inneholdende syreaddisjonssaltet og anvendelsen derav for behandlingen av forstyrrelser forårsaket av en svikt i cC.V- eller muskarinsystemet.The present invention relates to a malate acid addition salt of 5- (2-ethyl-2-t-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine, pharmaceutical compositions containing the acid addition salt and its use in the treatment of disorders. caused by a failure of the cC.V or muscarinic system.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 | ||
| PCT/DK1998/000294 WO1999001448A1 (en) | 1997-07-01 | 1998-07-01 | 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO996580D0 NO996580D0 (en) | 1999-12-30 |
| NO996580L true NO996580L (en) | 1999-12-30 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO996580A NO996580L (en) | 1997-07-01 | 1999-12-30 | 5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (en) |
| JP (1) | JP2002507215A (en) |
| KR (1) | KR20010014297A (en) |
| CN (1) | CN1261361A (en) |
| AR (1) | AR013096A1 (en) |
| AU (1) | AU735751B2 (en) |
| BG (1) | BG103933A (en) |
| BR (1) | BR9810331A (en) |
| CA (1) | CA2293324A1 (en) |
| CO (1) | CO4940483A1 (en) |
| EA (1) | EA200000081A1 (en) |
| HU (1) | HUP0002876A2 (en) |
| IL (1) | IL133093A0 (en) |
| IS (1) | IS5278A (en) |
| JO (1) | JO2031B1 (en) |
| MA (1) | MA25138A1 (en) |
| NO (1) | NO996580L (en) |
| PE (1) | PE116099A1 (en) |
| PL (1) | PL337184A1 (en) |
| SK (1) | SK187399A3 (en) |
| TN (1) | TNSN98120A1 (en) |
| TR (1) | TR199903283T2 (en) |
| UY (2) | UY25069A1 (en) |
| WO (1) | WO1999001448A1 (en) |
| ZA (1) | ZA985498B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| CZ287441B6 (en) * | 1995-11-06 | 2000-11-15 | Lundbeck & Co As H | Pharmaceutical preparation for treating traumatic lesion of brain |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/en not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/en unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/en not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/en unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/en not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/en unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/en unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/en active Pending
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 PL PL98337184A patent/PL337184A1/en unknown
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/en unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/en unknown
- 1998-07-01 MA MA25155A patent/MA25138A1/en unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/en not_active Application Discontinuation
- 1998-07-01 SK SK1873-99A patent/SK187399A3/en unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 CN CN98806497A patent/CN1261361A/en active Pending
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 EA EA200000081A patent/EA200000081A1/en unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/en not_active Application Discontinuation
- 1998-09-10 UY UY25177A patent/UY25177A1/en not_active Application Discontinuation
-
1999
- 1999-11-30 BG BG103933A patent/BG103933A/en unknown
- 1999-11-30 IS IS5278A patent/IS5278A/en unknown
- 1999-12-30 NO NO996580A patent/NO996580L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU735751B2 (en) | 2001-07-12 |
| EA200000081A1 (en) | 2000-08-28 |
| PL337184A1 (en) | 2000-08-14 |
| TR199903283T2 (en) | 2000-06-21 |
| JP2002507215A (en) | 2002-03-05 |
| BR9810331A (en) | 2000-09-05 |
| CA2293324A1 (en) | 1999-01-14 |
| ZA985498B (en) | 1999-01-20 |
| CO4940483A1 (en) | 2000-07-24 |
| UY25177A1 (en) | 2000-12-29 |
| NO996580D0 (en) | 1999-12-30 |
| SK187399A3 (en) | 2000-06-12 |
| PE116099A1 (en) | 1999-11-23 |
| UY25069A1 (en) | 1998-12-21 |
| AR013096A1 (en) | 2000-12-13 |
| CN1261361A (en) | 2000-07-26 |
| MA25138A1 (en) | 2001-04-02 |
| HUP0002876A2 (en) | 2001-06-28 |
| EP0994869A1 (en) | 2000-04-26 |
| JO2031B1 (en) | 1999-05-15 |
| WO1999001448A1 (en) | 1999-01-14 |
| BG103933A (en) | 2000-07-31 |
| TNSN98120A1 (en) | 2005-03-15 |
| IL133093A0 (en) | 2001-03-19 |
| IS5278A (en) | 1999-11-30 |
| AU8102098A (en) | 1999-01-25 |
| KR20010014297A (en) | 2001-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE203019T1 (en) | NEW (R)-5-CARBAMOYL-8-FLUORINE-3-N,N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANES | |
| BG103297A (en) | Aralkyl and aralkyliden heterocyclic lactams and imides | |
| MY128654A (en) | Liquid pharmaceutical composition containing an erythropoietin derivative | |
| DE69307340D1 (en) | CHINUCLIDINE DERIVATIVE AS SUBSTANCE P ANTAGONIST | |
| HK1008819A1 (en) | Piperidine derivatives as neurokinin antagonists | |
| NO985977L (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| EP0896533A4 (en) | Pentafluorobenzenesulfonamides and analogs | |
| CA2129995A1 (en) | Piperidinyl thiacyclic derivatives | |
| TR200101962T2 (en) | 4- (aminomethyl) -piperidine benzamides to treat digestive system disorders | |
| DE69941255D1 (en) | CONNECTIONS WITH GROWTH HORMONE RELEASING PROPERTIES | |
| PT615751E (en) | UTILIZATION OF TAQUININE ANTAGONISTS IN EMESE TREATMENT | |
| TNSN96174A1 (en) | AZETIDINES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| FI943499A0 (en) | Acid surrogate containing tetrahedro-1H-benzazepinones | |
| DE69925270D1 (en) | MEANS TO TREAT JUCKREIZ, CONTAINING PGD2 ANTAGONISTS | |
| NO975681L (en) | Benzisoxazole and indazole derivatives as antipsychotic agents | |
| NO20000519L (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
| WO2002005801A3 (en) | Compositions containing diacyltartaric salts of (e)-metanicotine | |
| BG103306A (en) | Liquid allendronate compositions | |
| WO1996031208A3 (en) | Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders | |
| ATE187956T1 (en) | SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS | |
| NO930205D0 (en) | BENZIMIDAZOLES, PHARMACEUTICALS CONTAINING THESE, AND PROCEDURE FOR THEIR PREPARATION | |
| NO996580L (en) | 5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate | |
| EA199700032A1 (en) | DISINFECTING COMPOSITION "VELTOLEN" | |
| CA2217463A1 (en) | Use of sulbutiamine to obtain pharmaceutical compositions which are useful in the treatment of some psychomotor and psychointellectual disorders | |
| TR200101476T2 (en) | The use of N-substituted azabicycloacane derivatives in the treatment of central nervous system disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |